• Visiting addressShow on map

    Sölvegatan 17, BMC A12

    221 84 Lund


Unit profile


The ultimate goal of our research is to be able to provide an alternative and unlimited source of HLA match hematopoietic stem cells (HSC) for patients in need of HSC transplantation. Our research aims to understand the molecular processes involved in HSC development to be able to mimic normal in vivo development of HSCs in a laboratory culture system. We have already identified numerous of critical factors influencing different stages of the developmental commitment towards the blood lineage. More recently, using single cell transcriptomics we have identified novel precursor cell populations undergoing endothelial-to-hematopoietic transition (EHT). We are first to be able to capture these cells and have functionally assessed their potential. Our research platform allows us characterize the factors required HSC developmental by studying the immediate precursor cells that give rise to HSCs in vitro and comparing them with similar cells from in vivo sources.

UKÄ subject classification

  • Cancer and Oncology
  • Clinical Laboratory Medicine

Free keywords

  • Pluripotent stem cell
  • induced pluripotent stem cell
  • hematopoietic stem cell
  • endothelial to hematopoietic transition
  • developmental biology
  • stem cell transplantation

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Collaborations the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or